Svenska Cellulosa Ab Sca Class A · OMXSTO:SCA_A

Svenska Cellulosa Ab Sca Class A — SCA — Q2 2014 Earnings Presentation

17 slides from Svenska Cellulosa Ab Sca Class A's earnings presentation, Jul 18, 2014

  1. Slide 1: SCA Interim Report Q2 2014

    SCA Interim Report B® Q2 2014 aoe ns Bs 1] ell i

  2. Slide 2: Q2 2014 Market Update

    Q2 2014 Market Update Tissue Stable demand for tissue in Europe Some growth for AfH tissue in North America Increased demand in emerging markets Personal Care Stable demand for personal care products in Europe Increased demand in emerging markets Forest Products Decreased demand for publication pape

  3. Slide 3: Summary

    Summary Q2 2014 vs. Q2 2013 Stable market demand in mature markets and higher market demand in emerging markets Good organic sales growth Strong increase of EBIT and EBIT-margin Efficiency programs delivering according to plan Several launches of new innovations and products Libero, Libresse, TENA a

  4. Slide 4: SCA and Vinda to integrate hygiene business in China

    SCA and Vinda to integrate hygiene business in China SCA to transfer its hygiene business in China (Mainland China, Hong Kong and Macau) to Vinda Exclusive license for Vinda to market and sell SCA brands; TENA, Tork, Tempo, Libero and Libresse in China Vinda to acquire SCA’s Dr P and Sealer brands i

  5. Slide 5: Group

    Group Q2 2014 vs. Q2 2013 Sales Organic Sales Growth Operating Profit* SEK SEK 25,829m +3% 2,934m +12% +29% Operating Margin* EPS Operating Cash Flow SEK 11.4% SEK 2.54 2,060m +150 bp +56% +28% * Excluding items affecting comparability and including gains on forest swaps of SEK 175m (0) before tax J

  6. Slide 6: Innovations and Product Launches

    Innovations and Product Launches Q2 2014 TENA Libresse Libero Lady / Lady Pants Multistyle Liners / CurveFitTM Comfort / Up&Go  Global relaunch of TENA  New Libresse Multistyle, the most Comfort: Elastics smoother and softer Lady and Lady pants absorbent liners designed around the legs, improved

  7. Slide 7: Innovations and Product Launches

    Innovations and Product Launches Q2 2014 Tork Sanitizing Tork - Bloe Tork - EasyCubeTM Wet Wipe  IT-based washroom service  IT-based washroom service  Wet wipes for cleaning and  Provides easily accessible real-  Provides easily accessible real- sanitizing restaurant tables time data on toilet

  8. Slide 8: Group

    Group Q2 2014 vs. Q2 2013 Sales growth 12% Organic sales growth of 3% All business areas show organic sales growth Good growth for the hygiene business in emerging markets Good growth for Forest Products Operating Profit Operating profit increased 29%* SEK 2,934m Organic operating profit growth 11%*

  9. Slide 9: Net Sales

    Net Sales Q2 2014 vs. Q2 2013 +2% SEK 25,829m +7% +2% +1% SEK 23,119m + 12% Net sales Price/Mix Volume Acquisition Currency Net sales Q2 2013 Q2 2014 Organic sales growth 3.3% Price/Mix +2% Volume +1% July 18, 2014 SCA Interim Report Q2 2014 9

  10. Slide 10: Group: Organic Sales Growth by region

    Group Organic Sales Growth Q2 2014 vs. Q2 2013 By region +9%  Emerging markets  Strong growth in Eastern Europe, Russia and Latin America - Feminine care in Latin America +19% - Incontinence products in Latin America +23% - Incontinence products in Russia +29% - Tissue in Russia +22% +3%  Mature

  11. Slide 11: Q2 2014 Results

    Q2 2014 Results SEK millions Q2 Q2 Change unless otherwise stated 2014 2013 % Net sales 25,829 23,119 12 Operating profit* 2,934 2,278 29 Operating margin* (%) 11.4 9.9 Profit before tax* 2,739 2,051 34 Earnings per share (SEK) 2.54 1.63 56 Operating cash flow 2,060 1,606 28 Debt/Equity ratio 0.56 0

  12. Slide 12: Personal Care

    Personal Care Q2 2014 vs Q2 2013  Sales growth 4% Net Sales Operating Profit* Operating Margin* SEK 902m  Organic sales growth 4%  Price/mix +2% SEK 7,475m SEK 7,750m SEK 877m 12.1% 11.3%  Volume +2%  Strong growth in emerging markets  Growth in all product segments Q2 2013 Q2 2014 Q2 2013 Q2

  13. Slide 13: Tissue

    Tissue Q2 2014 vs Q2 2013 Net Sales Operating Profit* Operating Margin*  Sales growth 18% SEK 14,039m SEK 1,652m  Organic sales growth 2% SEK 11,930m SEK 1,333m 11.2% 11.8%  Price/mix +1%  Volume +1%  Strong growth in emerging markets  Good growth for AfH tissue Q2 2013 Q2 2014 Q2 2013 Q2 2014

  14. Slide 14: Forest Products

    Forest Products Q2 2014 vs Q2 2013  Sales growth 11% Net Sales Operating Profit* Operating Margin*  Price/mix +6% SEK 4,217m SEK 623m 14.8%  Volume +4% SEK 3,788m  Currency +1%  Growth in all product segments SEK 250m 6.6%  Operating profit increased 149%* Q2 2013 Q2 2014 Q2 2013 Q2 2014 Q2 20

  15. Slide 15: Summary

    Summary Q2 2014 vs. Q2 2013 Stable market demand in mature markets and higher market demand in emerging markets Good organic sales growth Strong increase of EBIT and EBIT-margin Efficiency programs delivering according to plan Several launches of new innovations and products Libero, Libresse, TENA a

  16. Slide 16: Q&A

    Q&A July 18, 2014 SCA Interim Report Q2 2014 16

  17. Slide 17: Slide 17

SCA — Q2 2014 Earnings Presentation on 6ix